Trials / Withdrawn
WithdrawnNCT06114121
Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.
Comparing Intrathecal Morphine and Erector Spinae Plane Regional Anesthesia Against Intrathecal Morphine Alone for Post-Cesarean Section Pain
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | erector spinae plane block (ESP) | nerve block for abdominal pain. administered once immediately prior to spinal anesthetic standard of care. |
| DRUG | Duramorph | 100 micrograms (mcg) of morphine administered in the spinal medications one time. |
| DRUG | Ropivacaine | Ropivacaine 0.5% between 20-40 milliliters will be administered once in the ESP block (in the spine) depending on patient weight to keep under the maximum dose. |
| DRUG | Bupivacaine Injection | Bupivacaine 0.75% 1.4-1.7 milliliters (10-12 milligrams) spinal medication. administered one time. |
Timeline
- Start date
- 2024-07-10
- Primary completion
- 2024-09-10
- Completion
- 2024-09-10
- First posted
- 2023-11-02
- Last updated
- 2024-09-19
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06114121. Inclusion in this directory is not an endorsement.